questionsmedicales.fr
Régions géographiques
Océanie
Australasie
Australasie : Questions médicales fréquentes
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Australasie : Questions médicales les plus fréquentes",
"headline": "Australasie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Australasie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-22",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Australasie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Océanie",
"url": "https://questionsmedicales.fr/mesh/D044349",
"about": {
"@type": "MedicalCondition",
"name": "Océanie",
"code": {
"@type": "MedicalCode",
"code": "D044349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Australie",
"alternateName": "Australia",
"url": "https://questionsmedicales.fr/mesh/D001315",
"about": {
"@type": "MedicalCondition",
"name": "Australie",
"code": {
"@type": "MedicalCode",
"code": "D001315",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Territoire de la capitale australienne",
"alternateName": "Australian Capital Territory",
"url": "https://questionsmedicales.fr/mesh/D020958",
"about": {
"@type": "MedicalCondition",
"name": "Territoire de la capitale australienne",
"code": {
"@type": "MedicalCode",
"code": "D020958",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nouvelle-Galles du Sud",
"alternateName": "New South Wales",
"url": "https://questionsmedicales.fr/mesh/D009517",
"about": {
"@type": "MedicalCondition",
"name": "Nouvelle-Galles du Sud",
"code": {
"@type": "MedicalCode",
"code": "D009517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Territoire du Nord",
"alternateName": "Northern Territory",
"url": "https://questionsmedicales.fr/mesh/D015876",
"about": {
"@type": "MedicalCondition",
"name": "Territoire du Nord",
"code": {
"@type": "MedicalCode",
"code": "D015876",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Queensland",
"alternateName": "Queensland",
"url": "https://questionsmedicales.fr/mesh/D011793",
"about": {
"@type": "MedicalCondition",
"name": "Queensland",
"code": {
"@type": "MedicalCode",
"code": "D011793",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.937"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Australie-Méridionale",
"alternateName": "South Australia",
"url": "https://questionsmedicales.fr/mesh/D013021",
"about": {
"@type": "MedicalCondition",
"name": "Australie-Méridionale",
"code": {
"@type": "MedicalCode",
"code": "D013021",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.968"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tasmanie",
"alternateName": "Tasmania",
"url": "https://questionsmedicales.fr/mesh/D013648",
"about": {
"@type": "MedicalCondition",
"name": "Tasmanie",
"code": {
"@type": "MedicalCode",
"code": "D013648",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.984"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Victoria",
"alternateName": "Victoria",
"url": "https://questionsmedicales.fr/mesh/D014739",
"about": {
"@type": "MedicalCondition",
"name": "Victoria",
"code": {
"@type": "MedicalCode",
"code": "D014739",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.992"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Australie occidentale",
"alternateName": "Western Australia",
"url": "https://questionsmedicales.fr/mesh/D014904",
"about": {
"@type": "MedicalCondition",
"name": "Australie occidentale",
"code": {
"@type": "MedicalCode",
"code": "D014904",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.996"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nouvelle-Zélande",
"alternateName": "New Zealand",
"url": "https://questionsmedicales.fr/mesh/D009520",
"about": {
"@type": "MedicalCondition",
"name": "Nouvelle-Zélande",
"code": {
"@type": "MedicalCode",
"code": "D009520",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.747"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Iles du Pacifique",
"alternateName": "Pacific Islands",
"url": "https://questionsmedicales.fr/mesh/D010139",
"about": {
"@type": "MedicalCondition",
"name": "Iles du Pacifique",
"code": {
"@type": "MedicalCode",
"code": "D010139",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.873"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Australasie",
"alternateName": "Australasia",
"code": {
"@type": "MedicalCode",
"code": "D044362",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ainsley J Newson",
"url": "https://questionsmedicales.fr/author/Ainsley%20J%20Newson",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, The University of Sydney, Sydney, NSW, Australia."
}
},
{
"@type": "Person",
"name": "Thomas Beaney",
"url": "https://questionsmedicales.fr/author/Thomas%20Beaney",
"affiliation": {
"@type": "Organization",
"name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK."
}
},
{
"@type": "Person",
"name": "Xin Xia",
"url": "https://questionsmedicales.fr/author/Xin%20Xia",
"affiliation": {
"@type": "Organization",
"name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK."
}
},
{
"@type": "Person",
"name": "Neil R Poulter",
"url": "https://questionsmedicales.fr/author/Neil%20R%20Poulter",
"affiliation": {
"@type": "Organization",
"name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37511475",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241411715"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36894035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.gastro.2023.02.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.",
"datePublished": "2023-02-28",
"url": "https://questionsmedicales.fr/article/36855007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12350-023-03202-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optimal age to stop prostate cancer screening and early detection.",
"datePublished": "2023-08-19",
"url": "https://questionsmedicales.fr/article/37598870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcpo.2023.100443"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.",
"datePublished": "2022-10-03",
"url": "https://questionsmedicales.fr/article/36121650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijc.34298"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Océanie",
"item": "https://questionsmedicales.fr/mesh/D044349"
},
{
"@type": "ListItem",
"position": 4,
"name": "Australasie",
"item": "https://questionsmedicales.fr/mesh/D044362"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Australasie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Australasie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Australasie",
"description": "Comment diagnostiquer une maladie tropicale en Australasie ?\nQuels tests sont utilisés pour le paludisme en Australasie ?\nComment identifier une infection par le virus Zika ?\nQuels sont les signes d'une infection à leptospirose ?\nComment diagnostiquer une maladie de Lyme en Australasie ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Early+Detection+of+Cancer&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Australasie",
"description": "Quels sont les symptômes du chikungunya ?\nComment se manifeste la dengue ?\nQuels signes indiquent une infection par le virus de l'herpès ?\nQuels symptômes d'une intoxication alimentaire ?\nComment reconnaître une infection respiratoire ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Early+Detection+of+Cancer&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Australasie",
"description": "Comment prévenir la dengue en Australasie ?\nQuelles mesures pour éviter le chikungunya ?\nComment se protéger contre le virus Zika ?\nQuelles sont les recommandations pour la leptospirose ?\nComment prévenir les infections respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Early+Detection+of+Cancer&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Australasie",
"description": "Quels traitements pour la dengue ?\nComment traiter une infection par le virus Zika ?\nQuels médicaments pour le chikungunya ?\nComment traiter une infection à leptospirose ?\nQuels sont les traitements pour la maladie de Lyme ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Early+Detection+of+Cancer&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Australasie",
"description": "Quelles complications peuvent survenir avec la dengue ?\nQuels risques associés au chikungunya ?\nQuelles complications de l'infection par le virus Zika ?\nQuelles complications de la leptospirose ?\nQuels risques de la maladie de Lyme non traitée ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Early+Detection+of+Cancer&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Australasie",
"description": "Quels sont les facteurs de risque pour la dengue ?\nQui est à risque pour le chikungunya ?\nQuels facteurs augmentent le risque de virus Zika ?\nQuels sont les risques associés à la leptospirose ?\nQui est à risque pour la maladie de Lyme ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Early+Detection+of+Cancer&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie tropicale en Australasie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur l'historique médical, les symptômes et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le paludisme en Australasie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de diagnostic incluent les frottis sanguins et les tests de dépistage rapide."
}
},
{
"@type": "Question",
"name": "Comment identifier une infection par le virus Zika ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'infection est confirmée par des tests sanguins spécifiques et l'historique de voyage."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une infection à leptospirose ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs musculaires et éruption cutanée, nécessitant des tests."
}
},
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie de Lyme en Australasie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'exposition aux tiques et des tests sérologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du chikungunya ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs articulaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la dengue ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dengue se manifeste par une forte fièvre, des douleurs corporelles et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection par le virus de l'herpès ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des lésions cutanées, des démangeaisons et des douleurs localisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une intoxication alimentaire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent nausées, vomissements, diarrhée et douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection respiratoire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, fièvre, essoufflement et douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dengue en Australasie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter le chikungunya ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des moustiquaires et des répulsifs, et éviter les zones infestées."
}
},
{
"@type": "Question",
"name": "Comment se protéger contre le virus Zika ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les piqûres de moustiques et utiliser des préservatifs lors de rapports sexuels."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour la leptospirose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact avec des eaux potentiellement contaminées et porter des vêtements de protection."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections respiratoires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter les contacts avec des personnes malades."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la dengue ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection par le virus Zika ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique ; le repos et l'hydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour le chikungunya ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anti-inflammatoires et les analgésiques sont utilisés pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection à leptospirose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend des antibiotiques et un suivi médical pour éviter les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour la maladie de Lyme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques sont le traitement principal, surtout s'ils sont administrés tôt."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la dengue ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dengue sévère, pouvant entraîner des hémorragies et un choc."
}
},
{
"@type": "Question",
"name": "Quels risques associés au chikungunya ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs articulaires chroniques peuvent persister longtemps après l'infection."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'infection par le virus Zika ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le virus peut causer des malformations congénitales si contracté pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quelles complications de la leptospirose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions rénales, hépatiques et des hémorragies pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels risques de la maladie de Lyme non traitée ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des problèmes neurologiques et des douleurs articulaires chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour la dengue ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent vivre dans des zones tropicales et avoir des antécédents d'infection."
}
},
{
"@type": "Question",
"name": "Qui est à risque pour le chikungunya ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées et celles avec des maladies chroniques sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de virus Zika ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Voyager dans des zones endommagées par le virus et être enceinte augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels sont les risques associés à la leptospirose ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes travaillant en milieu rural ou en contact avec des eaux contaminées sont à risque."
}
},
{
"@type": "Question",
"name": "Qui est à risque pour la maladie de Lyme ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes vivant dans des zones boisées ou ayant des activités de plein air sont à risque."
}
}
]
}
]
}
The central objective of the metamorphosis of discovery science into biomedical applications is to serve the purpose of patients and curtail the global disease burden. The journey from the discovery o...
Diagnosing gastric cancer (GC) while the disease remains eligible for surgical resection is challenging. In view of this clinical challenge, novel and robust biomarkers for early detection thus improv...
The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastro...
In discovery phase, one LR (GClnc1) was found to be up-regulated in both tissue and circulating EV samples with an area under the curve (AUC) of 0.9369 (95% confidence interval [CI], 0.9073-0.9664) fo...
EV-derived GClnc1 serves as a circulating biomarker for the early detection of GC, thus providing opportunities for curative surgery and improved survival outcomes....
Cancer therapy-induced cardiotoxicity is an emerging clinical and healthcare issue. Myocardial dysfunction and heart failure are mostly responsible for increased cardiovascular mortality in cancer dis...
Prostate Cancer screening should be discontinued at older ages because competing mortality risks eventually dominate the risk of Prostate Cancer and harms exceed benefits. We explored the Prostate Can...
We applied Bellman Equations to formulate the net benefits biopsy and "do nothing". Using difference between the net benefits of two alternatives, we calculated the stopping age. The cancer states wer...
Our results suggested that Prostate Cancer screening stopping ages from the patient, healthcare system, and social were 70, 68, and 68 respectively. The univariate sensitivity analysis showed that the...
Men should not be screened for Prostate Cancer beyond 70 years old, as this results in the net benefit of "do nothing" above the biopsy. Nevertheless, this finding needs to be further studied with mor...
Colorectal cancer (CRC) develops mainly from colorectal advanced adenomas (AA), which are considered precancerous lesions. Novel early diagnostic biomarkers are urgently needed to distinguish CRC and ...
The modality to detect ovarian cancer at an early stage is very limited. Early diagnosis determines the prognosis. This study aimed to develop a risk assessment tool for early detection of ovarian can...
This study was carried out as a cohort study of patients diagnosed with suspected ovarian tumors undergoing cytoreduction operation at Hasan Sadikin Hospital, Bandung, from December 2019 to September ...
In total, 115 patients included in this study. The differences were statistically significant in terms of the six variables (abdominal bloating, nausea/vomiting, decreased of appetite, fullness, menst...
Risk assessments based on ovarian cancer self-assessment unfortunately were not comparable to postoperative histopathology as a single predictor. Ten variables in ovarian cancer artificial intelligenc...
Early detection of colorectal cancer (CRC) significantly enhances patient outcomes. Conventional CRC screening tools, like endoscopy and stool-based tests, have constraints due to their invasiveness o...
In this research, we harnessed the Mutation Capsule Plus (MCP) technology to profile an array of genomic characteristics from cfDNA procured from a single blood draw. This profiling encompassed DNA me...
This model was subsequently validated in another cohort comprising 89 CRC patients and 95 healthy controls. Remarkably, the model achieved an area under the curve (AUC) of 0.981 (95% confidence interv...
Our findings underscore the clinical potential of our multiomics liquid biopsy test, indicating its prospective role as a noninvasive method for early-stage CRC detection. This multiomics approach hol...
Clinical diagnostics rely heavily on the detection and quantification of cancer biomarkers. The rapid detection of cancer-specific biomarkers is of great importance in the early diagnosis of cancers a...
A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. ...
Hepatocellular carcinoma (HCC) is the fastest-rising and fourth most common cause of cancer death worldwide. Liver cirrhosis is the largest underlying risk factor for HCC. Therefore, patients with cir...
This is a UK-based prospective, longitudinal, diagnostic, prognostic, multicentre, non-CTIMP study. Aiming to recruit 3000 patients with liver cirrhosis without a HCC diagnosis, the Pearl cohort will ...
Ethical approval has been granted by REC and the trial is registered on ClinicalTrials.gov. The results will be published in peer-reviewed journals and presented at relevant meetings....
NCT05541601....